300966 共同藥業
按盤價 
17.970 +2.070 (+13.019%)
17.970 +2.070 (+13.019%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.539 | 2.446 | 4.634 | 11.677 | 10.492 |
| 總資產報酬率 ROA (%) | -0.196 | 1.019 | 2.451 | 7.772 | 6.570 |
| 投入資產回報率 ROIC (%) | -0.251 | 1.239 | 2.889 | 8.997 | 7.399 | 邊際利潤分析 |
| 銷售毛利率 (%) | 17.382 | 22.091 | 22.862 | 26.386 | 22.777 |
| 營業利潤率 (%) | -4.345 | 3.448 | 6.435 | 10.613 | 12.241 |
| 息稅前利潤/營業總收入 (%) | -1.806 | 5.206 | 8.051 | 15.467 | 14.391 |
| 淨利潤/營業總收入 (%) | -2.945 | 3.759 | 6.536 | 13.212 | 11.364 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 145.277 | 126.537 | 99.920 | 72.662 | 92.049 |
| 價值變動淨收益/利潤總額(%) | -2.239 | 1.289 | -0.474 | -1.219 | -0.408 |
| 營業外收支淨額/利潤總額(%) | 10.439 | -2.164 | -1.012 | 27.178 | 4.884 | 償債能力分析 |
| 流動比率 (X) | 1.216 | 1.267 | 2.107 | 2.576 | 2.346 |
| 速動比率 (X) | 0.734 | 0.690 | 1.356 | 1.462 | 1.533 |
| 資產負債率 (%) | 62.458 | 58.175 | 52.585 | 31.606 | 0.329 |
| 帶息債務/全部投入資本 (%) | 50.272 | 47.019 | 42.809 | 16.758 | 22.490 |
| 股東權益/帶息債務 (%) | 88.999 | 103.431 | 123.588 | 467.952 | 333.747 |
| 股東權益/負債合計 (%) | 54.690 | 66.908 | 85.291 | 210.813 | 202.034 |
| 利息保障倍數 (X) | -0.593 | 2.844 | 4.790 | 17.330 | 9.458 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 156.611 | 121.732 | 106.324 | 119.245 | 146.086 |
| 存貨周轉天數 (天) | 366.060 | 338.014 | 310.224 | 236.696 | 221.197 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
